Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy

Podobne zapisy

• Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
  od: Liu, Hongchuan, i wsp.
  Wydane: (2019)
• The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy
  od: Chen, Danqing, i wsp.
  Wydane: (2019)
• The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
  od: Shi, Rui, i wsp.
  Wydane: (2020)
• Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy
  od: Liu, Kefang, i wsp.
  Wydane: (2017)
• Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies
  od: Tan, Shuguang, i wsp.
  Wydane: (2016)